Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Transfusion|February 7, 2022
Antibody profiles in COVID-19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatmentAnil Bagri, Rafael R de Assis, Cheng-Ting Tsai, et al.Cancer Cell|April 9, 2008
Blocking neuropilin-2 function inhibits tumor cell metastasisMaresa Caunt, Judy Mak, Wei-Ching Liang, et al.Developmental Cell|January 18, 2011
Robo4 maintains vessel integrity and inhibits angiogenesis by interacting with UNC5BAlexander W Koch, Thomas Mathivet, Bruno Larrivée, et al.Nature Communications|July 21, 2022
Detection of neutralizing antibodies against multiple SARS-CoV-2 strains in dried blood spots using cell-free PCRKenneth Danh, Donna Grace Karp, Malvika Singhal, et al.Biorxiv : the Preprint Server for Biology|June 9, 2020
Analysis of SARS-CoV-2 Antibodies in COVID-19 Convalescent Blood using a Coronavirus Antigen MicroarrayRafael R de Assis, Aarti Jain, Rie Nakajima, et al.Nature Communications|January 5, 2021
Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarrayRafael R de Assis, Aarti Jain, Rie Nakajima, et al.Drug Delivery and Translational Research|January 17, 2020
Translational studies of intravenous and intracerebroventricular routes of administration for CNS cellular biodistribution for BMN 250, an enzyme replacement therapy for the treatment of Sanfilippo type BAnita Grover, Danielle Crippen-Harmon, Lacey Nave, et al.Transfusion|September 2, 2022
Characterization of pathogen-inactivated COVID-19 convalescent plasma and responses in transfused patientsMaja Weisser, Nina Khanna, Anemone Hedstueck, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 2014
Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIBShih-Hsin Kan, Mika Aoyagi-Scharber, Steven Q Le, et al.Pageof 3